A Single Proximal Interlocking Bolt May Be Sufficient for Retrograde Nailing of Extra-articular Femur Fractures.

Autor:	Campbell ST; Department of Orthopaedic Surgery, UC Davis Medical Center, Sacramento, CA., Dhillon E; Department of Orthopaedic Surgery, Harborview Medical Center, Seattle WA., Sliepka J; Department of Orthopaedic Surgery, Harborview Medical Center, Seattle WA., Higgins A; Department of Orthopaedic Surgery, Harborview Medical Center, Seattle WA., DeBaun MR; Department of Orthopaedic Surgery, Duke University Hospital, Durham, NC; and., Goodnough LH; Department of Orthopaedic Surgery, Stanford Hospital, Palo Alto, CA., Agel J; Department of Orthopaedic Surgery, Harborview Medical Center, Seattle WA., Barei DP; Department of Orthopaedic Surgery, Harborview Medical Center, Seattle WA.
Jazyk:	angličtina
Zdroj:	Journal of orthopaedic trauma [J Orthop Trauma] 2022 Dec 01; Vol. 36 (12), pp. 610-614.
DOI:	10.1097/BOT.0000000000002439
Abstrakt:	Objective: To evaluate whether a single proximal interlocking bolt was sufficient during the treatment of extra-articular femur fractures with retrograde medullary nailing. Design: Retrospective comparative study. Setting: Academic Level 1 trauma center. Patients: The study included 136 patients with extra-articular femur fractures treated with retrograde medullary nailing who met inclusion and follow-up criteria. Intervention: The intervention included surgical treatment for a femur fracture with retrograde medullary nailing, with comparisons made between those treated with a single proximal interlocking (1 IL) bolt and those treated with 2 proximal interlocking bolts (2 IL). Main Outcome Measurement: The main outcome measurements were as follows: (1) rate of nonunion and (2) rate of catastrophic implant failure. Results: There was no difference in the rate of nonunion requiring surgical intervention between the 2 groups. There were no catastrophic failures in either group. Conclusions: A single proximal interlocking bolt may be sufficient when using retrograde nailing for the treatment of extra-articular femur fractures. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence. Competing Interests: The authors report no conflict of interest. (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu